GAGE12G

Q-omics provides the consensus-scored GAGE12G profile across patient tissues and cancer cell-line models. GAGE12G expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, GAGE12G RNA expression shows 1 significant drug associations, with the highest sampling consensus in PEMB_ALL. Together, these results highlight STAD, and PEMB_ALL as cancer lineages where GAGE12G shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes GAGE12G survival associations across molecular data types. GAGE12G RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

GAGE12G data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	STAD (36)	view →

This table ranks reproducible GAGE12G RNA expression–survival associations across cancer types. High GAGE12G expression shows unfavorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .039). Together, the overview and detailed table identify STAD as the clearest survival context for GAGE12G RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.251	0.688	.039	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

GAGE12G-STAD (OS)

Explore this curve interactively →